Motilal Oswal is bullish on TeamLease recommended buy rating on the stock with a target price of Rs 2890 in its research report dated June 06, 2023.
Dominant presence in a few of the pharma intermediates and the emerging op-portunities in chemical applications are key growth drivers
Ahead of the Reserve Bank of India's rate decision, market participants are likely to remain cautious, as was seen the previous day when the benchmarks ended flat after choppy trade
Mishra Dhatu Nigam has experienced a breakout of a bullish Inverse Head and Shoulder pattern on the daily chart. It has retested its previous breakout level of Rs 213 and starts a new leg of the rally towards Rs 280.
The momentum indicator RSI is rising and sustained above 60 level on all the time frame indicating strong positive momentum of the stock.
Traders can hold their long position in the stock with a revised stop-loss of Rs 520, Anand Rathi's Head of Technical Research Mehul Kothari advised
Sharekhan is bullish on Strides Pharma Sciences Ltd has recommended buy rating on the stock with a target price of Rs 450 in its research report dated June 01, 2023.
Sharekhan is bullish on Insecticides (India) Ltd has recommended buy rating on the stock with a target price of Rs 540 in its research report dated June 01, 2023.
Sharekhan is bullish on Gateway Distriparks has recommended buy rating on the stock with a target price of Rs 80 in its research report dated June 01, 2023.
Sharekhan is bullish on Lumax Auto Technologies has recommended buy rating on the stock with a target price of Rs 406 in its research report dated May 02, 2023.
Axis Bank, Balkrishna Industries, Hindustan Unilever, Sonata Software, Kotak Mahindra Bank, UNO Minda bet on these six stocks for an upside of upto 22 percent in the month of June 2023.
Nuvoco Vistas Corporation has broken out on the daily chart from the downward sloping trendline, adjoining the highs of September 20, 2022 and February 8, 2023.
eClerx Services has also formed strong bullish candlestick pattern on the daily charts with above average volumes as the stock jumped more than 6 percent to Rs 1,715, the highest closing level since January 20, 2022. The stock has seen a breakout of last four-day consolidation.
Kotak Institutional Equities is bullish on Kfin Technologies has recommended buy rating on the stock with a fair value at Rs 400 in its research report dated May 17, 2023.
Motilal Oswal recommended Neutral rating on Hindustan Zinc with a target price of Rs 300 in its research report dated June 01, 2023.
Motilal Oswal recommended Neutral rating on Aegis Logistics with a target price of Rs 330 in its research report dated June 01, 2023.
Motilal Oswal is bullish on Lemon Tree Hotels recommended buy rating on the stock with a target price of Rs 115 in its research report dated June 01, 2023.
This week, 18,650-18,700 is expected to be a crucial hurdle and, if the index decisively surpasses this area, then 18,800-19,000 levels can't be ruled out
Fertiliser firm to gain from cost efficiencies and improved capacity in FY24/25
Broking firm Axis Securities picked ICICI Bank, Maruti Suzuki India, State Bank of India, Varun Beverages, and ITC with an upside of up to 22 percent in the month of June 2023.
The entire Healthcare space has been buzzing and seems to be finding its mojo back. Along with pharmaceutical companies, ‘Apollo Hospitals’ too performed well throughout this week.
Going ahead, the recent high of 18,662 would remain an immediate trigger for the bulls. A sustainable move above the same might result in a new life high for the Nifty50.
Prabhudas Lilladher is bullish on S Chand and Company has recommended buy rating on the stock with a target price of Rs 257 in its research report dated May 31, 2023.
Prabhudas Lilladher is bullish on Apollo Hospitals Enterprise has recommended buy rating on the stock with a target price of Rs 5300 in its research report dated June 01, 2023.
Prabhudas Lilladher recommended accumulate rating on Insecticides India with a target price of Rs 550 in its research report dated June 31, 2023.